David Hutton


AAO applauds Congress for passage of key milestone for Improving Seniors' Timely Access to Care Act of 2021

May 13, 2022

The American Academy of Ophthalmology applauded Congress for reaching the 290-consponsor milestone for the proposal. By reaching the two-thirds majority of bipartisan support in Congress, the bill is eligible for inclusion on the Consensus Calendar under new rules that were established in 2019.

Phase 2 INTEGRAL trial: THR-689 fails to meet primary endpoints in eyes with DME, will not advance

May 10, 2022

According to the company, the trial did not demonstrate efficacy on the key clinical endpoints. As a result, Oxurion will now shift its focus to the Phase 2 development program for THR-149, which recently demonstrated a compelling safety and efficacy profile for the treatment of DME.